Dopamine And Norepinephrine Reuptake Inhibitors
- Name
- Dopamine And Norepinephrine Reuptake Inhibitors
- Accession Number
- DBCAT005675
- Description
Drugs that block specific transporter proteins, increasing the amount of active norepinephrine and dopamine neurotransmitters in the brain.
- Drugs
Drug Drug Description Solriamfetol Solriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients[FDA Label][A176534,A176744]. Bupropion A norepinephrine and dopamine reuptake inhibitor used in the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. - Drugs & Drug Targets